• GA-Driven Autophagic Degradation of DELLA Proteins in Arabid

  2026-05-09

  This study uncovers a novel autophagy pathway in which gibberellin (GA) triggers ATG8-dependent autophagic degradation of DELLA proteins, promoting seed germination and skotomorphogenesis under nutrient starvation in Arabidopsis. These findings reveal a previously uncharacterized mechanism connecting hormonal signaling and protein homeostasis during early plant development.

• Acridine Orange hydrochloride: Practical Guide for Cytochemi

  2026-05-08

  Acridine Orange hydrochloride offers researchers a reliable, dual-fluorescence approach for differential DNA and RNA staining in flow cytofluorometric and cytochemical workflows. This product is best suited for cell cycle analysis, apoptosis detection, and nucleic acid-specific assays, but should not be applied to long-term solution storage or non-nucleic acid targets due to stability limits. Use is recommended where high purity, spectral separation, and reproducible QC are critical.

• E-64 and Lysoptosis: Precision Tools for Translational Resea

  2026-05-08

  Explore how E-64, a potent L-trans-epoxysuccinyl peptide, empowers translational researchers to dissect and manipulate lysosomal cell death pathways. This article bridges mechanistic insight from landmark lysoptosis studies with strategic guidance for experimental design, highlighting E-64’s competitive advantages and practical parameters for reliable cysteine protease inhibition.

• Oridonin Inhibits Esophageal Cancer by Modulating Inflammati

  2026-05-07

  Peng et al. (2025) provide direct evidence that oridonin suppresses esophageal cancer progression by inhibiting the TLR4/NF-κB/NLRP3 inflammasome pathway. Their findings clarify the mechanistic link between chronic inflammation and esophageal carcinogenesis, informing anti-cancer strategies focused on selective inflammation modulation.

• P2Y11 Antagonist NF 340: Precision Tool for GPCR Signaling S

  2026-05-07

  NF 340 stands out as a highly selective P2Y11 antagonist, empowering researchers to dissect purinergic GPCR signaling with reproducibility and specificity. Unlock robust experimental workflows in cancer, immunology, and inflammation pathway modulation with enhanced troubleshooting guidance and direct translation from recent peer-reviewed breakthroughs.

• Bardoxolone Methyl: Advanced Redox Modulation in Applied Res

  2026-05-06

  Bardoxolone methyl (CDDO methyl ester) stands out as a potent and versatile modulator of Nrf2 and NF-kB signaling, enabling researchers to dissect oxidative stress and inflammation with precision. Recent advances leveraging redox pathway insights, including combinatorial strategies in cancer and kidney models, place Bardoxolone methyl at the frontier of applied redox biology.

• Ceftolozane-Tazobactam Advances for Nosocomial Pneumonia Res

  2026-05-06

  The referenced study details the structural and pharmacodynamic innovations of ceftolozane-tazobactam for nosocomial pneumonia, emphasizing its potent activity against multidrug-resistant Pseudomonas aeruginosa and Enterobacteriaceae. These findings highlight new research opportunities in modeling resistance mechanisms and optimizing cephalosporin antibiotic protocols for severe bacterial infections.

• Protease Inhibitor Cocktail: Optimizing Protein Stability in

  2026-05-05

  Unlock high-fidelity lipid droplet metabolism studies with the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) from APExBIO. This advanced inhibitor mixture streamlines protein extraction, preserves labile regulatory complexes, and supports reproducible outcomes in demanding cell and tissue workflows.

• Chlorpromazine HCl: Translational Leverage in Neuropharmacol

  2026-05-05

  This thought-leadership article explores how Chlorpromazine HCl, a classic dopamine receptor antagonist, enables new frontiers in translational neuropharmacology and cellular infection studies. Bridging mechanistic depth with practical protocol guidance, it contextualizes APExBIO’s product (SKU B1480) within both established and emerging assay paradigms. The piece highlights evidence from endocytosis-blocking infection research and differentiates itself by connecting the molecular logic of dopamine and GABAA receptor modulation to workflow-validated strategies for disease modeling, cell viability, and mechanistic discovery.

• TG003 Cdc2-like Kinase Inhibitor: Workflows for Splicing & P

  2026-05-04

  TG003, a nanomolar-potency Cdc2-like kinase inhibitor, empowers researchers to dissect alternative splicing and overcome platinum resistance in oncology and neuromuscular models. This guide delivers actionable protocols, advanced troubleshooting, and translational insights using APExBIO's TG003 for precise splicing modulation.

• CYR61-Mediated Migrasome Repair in Irradiated BMSCs: Mechani

  2026-05-04

  This study uncovers how the extracellular matrix protein CYR61, delivered via migrasomes, restores migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells (BMSCs). The findings highlight a specific integrin-ERK signaling mechanism and suggest new avenues for treating osteoradionecrosis-related bone defects.

• Protease Inhibitor Cocktail Elevates Lipid Droplet Assays

  2026-05-03

  Unlock robust protein stability in lipid droplet research using the Protease Inhibitor Cocktail (100X H₂O, EDTA Plus). This APExBIO solution uniquely preserves fragile complexes in nutrient-stress workflows and ensures data reproducibility across Western blotting, Co-IP, and proteomic applications.

• Sulfo-NHS-Biotin: Precision Tools for Translational Protein

  2026-05-02

  This thought-leadership article explores the mechanistic underpinnings and translational value of Sulfo-NHS-Biotin, a water-soluble, amine-reactive protein labeling reagent. It bridges foundational chemistry with strategic guidance for researchers navigating the challenges of target validation, biomarker discovery, and cell therapy development. Drawing on recent advances—including lessons from site-specific versus random biotinylation in IL7 research—this article contextualizes Sulfo-NHS-Biotin’s competitive edge, uncovers practical protocol insights, and anticipates future innovation in protein therapeutics and high-throughput biology.

• Dihydrotestosterone in Cancer & ALS Models: Protocols & Pitf

  2026-05-01

  Dihydrotestosterone (DHT) is a versatile tool for modeling androgen receptor signaling, EGFR pathway activation, and therapy resistance in both cancer and neurodegenerative disease research. This article delivers evidence-backed protocols, advanced application strategies, and troubleshooting insights to help researchers maximize experimental accuracy and translational relevance.

• Sulfo-NHS-Biotin: Raising the Bar in Cell Surface Protein La

  2026-05-01

  This thought-leadership article confronts the persistent challenge of achieving precise, high-fidelity cell surface protein labeling in translational research. We dissect the mechanistic strengths and workflow advantages of Sulfo-NHS-Biotin, referencing both the latest peer-reviewed insights and strategic application data, to guide researchers aiming for maximal reproducibility and functional retention. By integrating competitive benchmarking, protocol optimization, and translational relevance, this article offers a forward-looking blueprint for protein labeling that goes beyond standard product guides.

16007 records 1/1068 page Next 12345 下5页 Last page